The hottest Synthetic Biology Substack posts right now

Industrial biotechnology aims to transition our economy to more sustainable biomanufacturing.
Techno-Economic Analysis (TEA) helps forecast new technology's competitiveness in industrial markets.
Synonym's tool Scaler simplifies TEA for synthetic biologists, potentially changing the financing structure of biomanufacturing.

Software and data analytics are being used to transform biomanufacturing, making it easier to control the complex variables involved in producing biological products.
Invert, founded by Martin Permin, integrates with bioreactors and databases to help biomanufacturers manage and optimize their data using AI and analytics.
Invert's platform streamlines bioprocessing by providing tools to plan experiments, monitor processes, analyze results, model scale-up, and collaborate with partners.

The author introduces themselves and their background professionally.
The author discusses their interest in startups focusing on polymer chemistry.
There is a shift to intermittent publishing due to the abundance of content available.

Yeast, especially in precision fermentation, can be genetically modified to produce a wide range of chemicals, biologics, and medicines by augmenting their genes.
The main challenge in precision fermentation is reducing costs, particularly in the purification process where proteins are separated from complex solutions.
Novel techniques like self-cleaving tags and self-aggregating proteins offer promising solutions for purifying proteins in a cost-effective and efficient manner, potentially eliminating the need for expensive purification methods like column chromatography.

The rapid progress of biology is driven by advancements in DNA technology and communication.
The newsletter aims to highlight exciting new research in genetics, genomics, and bioinformatics.
The newsletter does not focus on peer review but instead aims to share exciting discoveries and findings.

Get a weekly roundup of the best Substack posts, by hacker news affinity:

UK is good, but not outstanding, in priority areas of science and technology.
Common metrics used to show UK as a science superpower may be misleading.
Need for increased investment and reform in UK's approach to funding cutting edge science.

A new computation paradigm of synthetic biology is gaining traction, transforming atoms to DNA sequences and allowing the growth of materials without complicated supply chains.
Podcasts are changing how people interact and could spark a new Age of Enlightenment.
Hollywood actors are on strike, while Elon Musk's Tesla is entering the UK energy market and launching a new xAI company.